44 results on '"Suárez-Fariñas, Mayte"'
Search Results
2. Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis
3. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis
4. Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles
5. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
6. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
7. An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis
8. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
9. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis
10. The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases
11. Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study
12. Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer
13. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
14. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
15. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets
16. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population
17. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
18. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin
19. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
20. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
21. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response
22. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
23. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities
24. Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis
25. Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis
26. Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation
27. Immune factors in breast milk related to infant milk allergy are independent of maternal atopy
28. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
29. Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB
30. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
31. Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept
32. Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases
33. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
34. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response
35. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets
36. Atopic dermatitis keratinocytes exhibit normal TH17 cytokine responses
37. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis
38. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
39. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
40. Natural History of Epitope-Specific IgD, IgG1, IgA, IgG4 and IgE Development in Peanut Allergic Children
41. Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence
42. A novel approach to the Basophil Activation Test (BAT) for characterizing peanut allergic patients in the clinical setting
43. Atopic dermatitis keratinocytes exhibit normal T H17 cytokine responses
44. Proteomic Profiling of Atopic Dermatitis, Psoriasis, and Contact Dermatitis Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.